KA1 inhibitors belong to a distinctive chemical class known for their capacity to modulate a specific biological target called potassium channel subfamily K member 1 (KCNK1). KCNK1, also referred to as acid-sensitive potassium channel 1 (TASK-1), is a member of the two-pore domain potassium (K2P) channels, playing a crucial role in cellular excitability and homeostasis. These channels are widely distributed in various tissues, including the brain, heart, and lungs, and are implicated in diverse physiological processes such as neuronal firing, cardiac rhythm regulation, and respiratory control.
The chemical structure of KA1 inhibitors is characterized by its ability to selectively interact with the TASK-1 channel, thereby modulating its activity. This modulation may involve blocking or enhancing the ion flow through the channel, ultimately influencing cellular responses associated with TASK-1 function. The design and development of KA1 inhibitors often require a deep understanding of the molecular interactions between the inhibitor and the channel, with researchers focusing on optimizing both affinity and selectivity. The intricate interplay between the chemical structure of KA1 inhibitors and the three-dimensional configuration of TASK-1 channels underscores the importance of structure-activity relationship studies in elucidating the pharmacological mechanisms of these compounds.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-Dione | 118876-58-7 | sc-478080 | 5 mg | $70.00 | 1 | |
NBQX is a competitive antagonist of AMPA/kainate receptors, which may indirectly inhibit GRIK4. | ||||||
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $105.00 $362.00 | ||
Topiramate, though primarily an anticonvulsant, has been shown to antagonize kainate receptors and may inhibit GRIK4. | ||||||
Ifenprodil hemitartrate | 23210-58-4 | sc-203601B sc-203601 sc-203601A | 5 mg 10 mg 50 mg | $39.00 $61.00 $142.00 | ||
Ifenprodil, an NMDA receptor antagonist, may also modulate GRIK4 activity indirectly through glutamatergic signaling. | ||||||
Kynurenic acid | 492-27-3 | sc-202683 sc-202683A sc-202683B | 250 mg 1 g 5 g | $25.00 $56.00 $135.00 | 6 | |
Kynurenic acid is a broad-spectrum antagonist of ionotropic glutamate receptors and can inhibit GRIK4-mediated signaling. | ||||||